References
- Pons-Estel GJ, Alarcon GS, Scofield L, et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010;39:257–68
- Medeiros PB, Febronio MV, Bonfa E, et al. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus 2009;18:38–43
- Pasoto SG, Mendonca BB, Bonfa E. Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 2002;11:175–80
- Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2008;26:436–41
- Medeiros MM, Silveira VA, Menezes AP, Carvalho RC. Risk factors for ovarian failure in patients with systemic lupus erythematosus. Braz J Med Biol Res 2001;34:1561–8
- Schaller J. Lupus in childhood. Clin Rheum Dis 1982;8:219–28
- Ekblom-Kullberg S, Kautiainen H, Alha P, et al. Reproductive health in women with systemic lupus erythematosus compared to population controls. Scand J Rheumatol 2009;38:375–80
- Gonzalez LA, Pons-Estel GJ, Zhang JS, et al. Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII). Lupus 2009;18:184–6
- Minami Y, Sasaki T, Komatsu S, et al. Female systemic lupus erythematosus in Miyagi Prefecture, Japan: a case-control study of dietary and reproductive factors. Tohoku J Exp Med 1993;169:245–52
- Silva CA, Hilario MO, Febronio MV, et al. Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study. Lupus 2007;16:531–6
- Moncayo-Naveda H, Moncayo R, Benz R, et al. Organ-specific antibodies against ovary in patients with systemic lupus erythematosus. Am J Obstet Gynecol 1989;160:1227–9
- McDermott EM, Powell RJ. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis 1996;55:224–9
- Park MC, Park YB, Jung SY, et al. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus 2004;13:569–74
- Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685–718
- Domingues TS, Rocha AM, Serafini PC. Tests for ovarian reserve: reliability and utility. Curr Opin Obstet Gynecol 2010;22:271–6
- Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725
- Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630–40
- Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363–9
- Rosen MP, Johnstone E, Addauan-Andersen C, Cedars MI. A lower antral follicle count is associated with infertility. Fertil Steril 2011;95:1950–4, 4 e1
- De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010;376:911–21
- Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606–14
- Browne H, Armstrong A, Decherney A, et al. Assessment of ovarian function with anti-Mullerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant. Fertil Steril 2009;91:1529–32
- Lawrenz B, Henes JC, Henes M, et al. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women – evaluation by using Anti-Mullerian hormone. Lupus 2011;20:1193–7